Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)

NCT07719257 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infections(cUTI)

Interventions

DRUG: TUL108
DRUG: Placebo
DRUG: TUL108

Sponsor

Zhuhai United Laboratories Co., Ltd.